Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.
Czyzyk J, Henegariu O, Preston-Hurlburt P, Baldzizhar R, Fedorchuk C, Esplugues E, Bottomly K, Gorus FK, Herold K, Flavell RA. J Immunol. 2012 Jun 15; 188(12):6319-27. Epub 2012 May 16.